Evozyne
Biotechnology ResearchIllinois, United States51-200 Employees
Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs.
Insights
New CEO Evozyne recently appointed Marc Yoskowitz as the CEO, signaling potential changes in leadership direction and a chance for new partnerships or collaborations.
Generative AI Model Evozyne is developing a generative AI model in collaboration with NVIDIA, presenting an opportunity to leverage cutting-edge technology for enhancing product development and attracting tech-savvy clients.
Series B Financing With a recent $81M funding in Series B, Evozyne has financial resources to expand operations, invest in research, and potentially seek new clients or strategic acquisitions.
Protein Therapeutics Evozyne specializes in designing novel protein therapeutics, offering a unique value proposition that can attract pharmaceutical companies looking for innovative solutions for unaddressed patient needs.
Market Trends In an industry where AI-driven solutions and biotech advancements are gaining traction, Evozyne's focus on AI models and high-performing proteins aligns well with current market trends, presenting opportunities for partnerships with forward-thinking organizations.
Similar companies to Evozyne
Carlsmed
84
$10M$50MC16 Biosciences
36$10MNotch Therapeutics
71$10M$50MInsilico Medicine
275$50M$100MLygos
85$10M$50MProteinQure
27$10MAbsci
188$10M$50MGRO Biosciences
33$10MArzeda
67$10M
Evozyne Tech Stack
Evozyne uses 8 technology products and services including GitHub, NoSQL, MySQL, and more. Explore Evozyne's tech stack below.
- GitHubCommunication And Collaboration
- NoSQLDatabase
- MySQLDatabase
- AsanaIssue Trackers
- ReactJavascript Frameworks
- JavaScriptProgramming Languages
- HaskellProgramming Languages
- LinuxProgramming Languages
Media & News
Evozyne's Email Address Formats
Evozyne uses at least 1 format(s):
| Evozyne Email Formats | Percentage |
| First.Last@evozyne.com | 50% |
| First.Last@evozyne.com | 50% |
Frequently Asked Questions
Where is Evozyne's headquarters located?
Evozyne's main headquarters is located at Chicago, IL US. The company has employees across 3 continents, including North AmericaAsiaEurope. What is Evozyne's official website and social media links?
Evozyne's official website is evozyne.com and has social profiles on LinkedIn.How much revenue does Evozyne generate?
As of October 2024, Evozyne's annual revenue reached $15M. What is Evozyne's SIC code NAICS code?
Evozyne's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Evozyne have currently?
As of October 2024, Evozyne has approximately 59 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Drug Discovery Officer: U. H.Vice President Operations: J. A.Head Of Computation: A. F.. Explore Evozyne's employee directory with LeadIQ.What industry does Evozyne belong to?
Evozyne operates in the Biotechnology Research industry. What technology does Evozyne use?
Evozyne's tech stack includes GitHubNoSQLMySQLAsanaReactJavaScriptHaskellLinux. What is Evozyne's email format?
Evozyne's email format typically follows the pattern of . Find more Evozyne email formats with LeadIQ. How much funding has Evozyne raised to date?
As of October 2024, Evozyne has raised $81M in funding. The last funding round occurred on Sep 27, 2023 for $81M.When was Evozyne founded?
Evozyne was founded in 2020.
Company Overview
- Headquarters
- Chicago, IL US
- Website
- evozyne.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2020
- Employees
- 51-200
Media & News
Funding & Financials
- $81M
Evozyne has raised a total of $81M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $81M.
- $10M$50M
Evozyne's revenue is in the range of $10M$50M
Funding & Financials
- $81M
Evozyne has raised a total of $81M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $81M.
- $10M$50M
Evozyne's revenue is in the range of $10M$50M
Company Leadership
U. H.Chief Drug Discovery Officer
J. A.Vice President Operations- A. F.Head Of Computation
- M. G.Vice Chairman Of The Board, Former Ceo
- R. A. B.Executive Assistant To The Ceo
Employee Directory
- J. A.Vice President Operations
- A. F.Head Of Computation
S. K.Senior Director, Talent + Hr- R. V.Senior Director Of Alliance Management
- A. L.Controller
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
